CNSL — Cambridge Nutritional Sciences Share Price
Last trade - 00:00- £7.73m
- £3.55m
- £7.55m
- 25
- 46
- 87
- 51
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.83 | ||
| Price to Tang. Book | 1.55 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.85 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -26.91% | ||
| Return on Equity | -30.47% | ||
| Operating Margin | -36.2% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 8.76 | 9.82 | 6.82 | 8.54 | 7.55 | 9 | n/a | -1.96% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | -85.8 | -83.93 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cambridge Nutritional Sciences plc is a United Kingdom-based specialist medical diagnostics company. The Company develops, manufactures and markets diagnostic products associated with food sensitivity and gut health. The Company serves healthcare professionals and the consumer directly with a focus on health and nutrition products.
Directors
- Last Annual
- March 31st, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- January 16th, 2004
- Public Since
- March 18th, 2004
- No. of Employees
- 91
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 237,950,660
- Address
- Eden Research Park, ELY, CB6 1SE
- Web
- https://www.omegadx.com/
- Phone
- +44 1353862220
- Auditors
- RSM UK Audit LLP
Latest News for CNSL
Upcoming Events for CNSL
Full Year 2024 Omega Diagnostics Group PLC Earnings Release
Omega Diagnostics Group PLC Annual Shareholders Meeting
Similar to CNSL
Abingdon Health
London Stock Exchange
Advanced Medical Solutions
London Stock Exchange
Advanced Oncotherapy
London Stock Exchange
Angle
London Stock Exchange
Aptamer
London Stock Exchange
FAQ
As of Today at 19:04 UTC, shares in Cambridge Nutritional Sciences are trading at 3.25p. This share price information is delayed by 15 minutes.
Shares in Cambridge Nutritional Sciences last closed at 3.25p and the price had moved by +22.64% over the past 365 days. In terms of relative price strength the Cambridge Nutritional Sciences share price has outperformed the FTSE All Share Index by +22.69% over the past year.
The overall consensus recommendation for Cambridge Nutritional Sciences is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Cambridge Nutritional Sciences does not currently pay a dividend.
Cambridge Nutritional Sciences does not currently pay a dividend.
Cambridge Nutritional Sciences does not currently pay a dividend.
To buy shares in Cambridge Nutritional Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 3.25p, shares in Cambridge Nutritional Sciences had a market capitalisation of £7.73m.
Here are the trading details for Cambridge Nutritional Sciences:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: CNSL
Based on an overall assessment of its quality, value and momentum Cambridge Nutritional Sciences is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Cambridge Nutritional Sciences is 10.00p. That is 207.69% above the last closing price of 3.25p.
Analysts covering Cambridge Nutritional Sciences currently have a consensus Earnings Per Share (EPS) forecast of -£0.30 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cambridge Nutritional Sciences. Over the past six months, its share price has outperformed the FTSE All Share Index by +74.46%.
As of the last closing price of 3.25p, shares in Cambridge Nutritional Sciences were trading +26.62% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Cambridge Nutritional Sciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 3.25p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Cambridge Nutritional Sciences' management team is headed by:
- Simon Douglas - NEC
- Jag Grewal - CEO
- Chris Lea - CFO
- William Rhodes - NED
- Jeremy Millard - NID